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Extrapolation of Carcinogenic Risk
from Animal Experiments to Man
by Lars Ehrenberg* and Bo Holmbergt
When estimating the absolute risk ofcancer, the shape ofthe dose-response curve in the region ofdoses
where actual exposure of man occurs is of crucial importance. This shape is equally important for the
determination ofrelative risks, as in the comparison ofrisks from alternative energy sources. Experimen-
tal and epidemiologic studies are, for various reasons, unable to give sufficiently exact information
concerning the dose response in the low dose region. Therefore, the discussion concerning dose-response
relationships also has to consider biologically reasonable mechanisms for the origin of tumors.
Mutation Hypothesis
Although it is realized that the development of
cancer is a two-step or multistep process, the cur-
rent hypothesis concerning the origin of cancer as-
sumes that one or a few mutational events are in-
volved in the initiation of tumors (1). This
hypothesis is supported not only by the strong,
qualitative correlation between mutagenic and car-
cinogenic activities ofchemicals but also by certain
reaction-kinetic considerations, viz., a favoring of
both the carcinogenic and the mutagenic potential
by a relatively high reactivity towards certain cen-
ters in DNA such as guanine-06 (2). In one case,
the role in cancer initiation of a well-defined chemi-
cal change in the DNA, the ultraviolet-induced
thymine dimer, has further been described (3).
Linearity of Dose Response
at Low Doses
A number of experiments in microorganisms,
plants, and animals give strong evidence that fre-
quencies of mutants observed in offspring genera-
tions after exposure to ionizing radiation or
mutagenic chemicals, depend linearly on dose in the
low-dose region (4). [Here "dose" refers to the tis-
sue dose Dt defined as the time integral of the con-
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centration in the target cells of the proximal
mutagen/carcinogen (5). Under certain conditions,
Dt is proportional to the exposure dose De.] If a
mutation process, comprising m mutational events
in each ofn cells, were rate-limiting in the origin of
tumors, a target-theoretical representation (6) ofthe
fraction of individuals with tumors, N*1NO, gives
N*INO = (1 - e-kD)mn
where D is dose and k is a proportionality constant.
A diagrammatic presentation in semilogarithmic
scale of the fraction of animals without tumors,
log(1- N*/NO) = log N/NO, as a function ofdose D
then approaches a straight line with the intercept
log mn at D = 0, permitting an estimate of the
number of targets mn. Such representation of ex-
perimental data from studies of both primary and
secondary carcinogens gives straight lines ex-
trapolating to log 1, i.e., mn = 1. With some care
required because of a possible sensitivity variation
of cells, which may lead to a decrease of the ex-
trapolation number (6), the conclusion would be
that in these cases a limiting step in the origin of
tumors consists in one mutational event in one cell,
and further that the dose-response curve is linear
from dose zero onwards. It should be kept in mind
that if the dose-response curve contains higher-
order terms ofthe dose, great care is required in the
decision, on the basis ofexperimental data, whether
a linear component exists at low doses, as well as in
the determination of its slope (7).
The involvement of one cell only is in agreement
with other observations in favor of a monoclonal
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response in the low-dose region, ofchemically and
radiation-induced cancer has been questioned, on
the basis of arguments which, in no case, are tena-
ble (4). For instance, the biochemical repair of
DNA damage is sometimes put forward as one fac-
tor contributing to a no-effect level below a safe
threshold dose (9). However, why should the DNA
repair be 100% effective for mutational events lead-
ing to cancer transformation when it is not for other
types of mutation? As a matter of fact, no proofs
exist against a linear dose response in studied cases
(and, therefore, of overall carcinogenicity of the
agents in question), and most indications of a safe
dose threshold may be explained as artifacts caused
by too small a sample size. In animal samples of
limited size, terms of higher order of the dose-
response curve will often predominate, partly as
functions of a cocarcinogenic or promoting action
of "complete" carcinogens, disturbances ofthe re-
pair systems, or enzyme induction, i.e., effects ex-
pected to require that a certain minimum dose is
exceeded.
Extrapolation from Animals to
Man
Extrapolation of data from acute toxic effects is
generally done from laboratory animals to human
exposures in quantitative terms, for instance, in
order to estimate safe levels of human exposures.
This is done with the assumption that physiological
parameters in animals and humans are comparable
(10). The calculation often involves the use of
safety factors. Few data are available for compari-
sons of late effects (11). The mechanism of tumor
induction is probably the same for humans and ani-
mals, although the risk, for e.g., for the mouse, may
differ from the human risk due to differences in up-
take, biotransformation, distribution, and elimina-
tion, i.e., in factors that determine actual tissue
doses.
The animal experiment is a rather crude instru-
ment for detecting carcinogenic activity. An exper-
iment dealing with 59 animals in each dose group
cannot detect a carcinogenic risk under 5% (12), a
risk level probably unacceptable in the human situa-
tion. Only by increasing the number of animals to
thousands and hundreds ofthousands, can low risk
levels thus be defined. This statement presupposes
that the control animals in the experimental system
will not show up with spontaneous tumors. Should
this be the case, the sensitivity of the conventional
test system is much further decreased (13). This
fact is an argument against extrapolating dose data
from conventional animal test systems to the human
exposure situation, particularly as far as large
human populations are concerned.
The fractionation of single doses of carcinogens,
i.e., the administration ofthe same total dose over a
long time period, seems to increase the response to
polycyclic hydrocarbons (14). Should this be a
characteristic of other carcinogens, it would mean
that the exposure to low doses over a long time
could be more effective than a short high-dose ex-
posure.
An inverted relationship between dose and la-
tency time has frequently been observed (15): a low
dose gives a long mean latency time and ahigh dose
a short mean latency time, although not proportion-
ally so (16). This has been taken as an indication
that it could, at least theoretically, be possible to
extrapolate to such a low dose that the mean la-
tency time exceeds the expected lifetime of the
species studies. Such a calculation does, however,
not take into account the fact that the variation in
latency time increases with decreasing dose. A
small dose may thus give individual latency times
within the expected lifetime although the mean la-
tency time for the group as a whole exceeds the life
span.
In the specific case of lung cancer, further argu-
ments against attempts to extrapolate experimental
dose data of carcinogens to so called no-effect
levels, or "safe" levels ofhuman exposure, are that
administration by inhalation is seldom used or is not
particularly effective in producing cancer in small
laboratory animals. The use of peroral administra-
tion or other routes ofadministration different from
the route of administration characteristic of the
human exposure makes quantitative extrapolation
even more difficult. Laboratory animals are fur-
thermore usually genetically well characterized,
they are exposed to one carcinogenic chemical in
their lifetime, the experiment is started at a similar
age and body weight, and other environmental con-
ditions are controlled for all individuals in the test
population. For human populations none of these
"ideal" conditions is present. The great variation in
biological sensitivity in human populations, for in-
stance, introduces an important drawback to a
quantitative extrapolation of experimental dose
data.
This is not to say that experimental dose-re-
sponse studies are useless. In fact, their most im-
portant contribution to the control of human expo-
sure to carcinogens lies in the applicability of the
mathematical models to epidemiologic data under
the aforenamed assumptions that the mechanism of
cancer induction and the toxicological parameters
of carcinogenic chemicals are the same in humans
Environmental Health Perspectivesand animals. When applying such a model to
epidemiological data it should, however, be re-
membered that a deviation from the linear dose-
response relationship, with a higher effectiveness of
lower doses, may occur at least for certain cancers
as observed for radiation (17), urethane (18), and
vinyl chloride (19, 20).
When considering extrapolation ofrisk to man of
a factor added to his environment it is of further
importance that human populations live under a
constant pressure of cancer-initiating as well as
cancer-promoting events. It was recently shown
(21) that, irrespective of the mathematical model
applied, any carcinogen added to this complicated
environment will cause an increment in the total
cancer incidence from dose zero onwards (of the
particular carcinogen considered). This conclusion
is valid for tumors with a monoclonal origin (8).
Methods to measure tissue doses Dt for primary
and secondary mutagens/carcinogens have been
suggested (5, 22). Furthermore, the risk ofmutation
relative to the corresponding risk for ionizing radia-
tion could be shown to follow a simple function of
the dose, which, since it was found tobe valid for so
widely differing organisms as bacteria, plants and
rodents, would at least preliminarily apply also to
man. Certain indications are at hand that the same
expression is valid also for induced cancer (23). If
further work can confirm that this is the case, and
since dose measurements can be applied directly to
exposed persons, a way would be at hand to over-
come many of the difficulties in estimating the
human risk.
This paper describes work supported by a grant to one of us
(L. Ehrenberg) from the Swedish Atomic Research Council.
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